Sign In
Buy CSTL
$24.69
-0.795 (-3.12%)
At Close: Jul 24, 2026
Castle Biosciences, Inc. (CSTL) Q1 2023 Earnings Call Transcript
11:07pm, Wednesday, 03'rd May 2023
Castle Biosciences, Inc. (NASDAQ:CSTL ) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ET Company Participants Camilla Zuckero - Vice President, Investor Relations & Corporate Affairs Derek Maet
7 Value Stocks to Buy for Long-Term Growth
01:50pm, Sunday, 26'th Mar 2023
For investors that have the patience to ride out volatility in exchange for possible long-term upside, value stocks to buy that are discounted against book value may offer considerable intrigue. On pa
Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
07:00am, Tuesday, 14'th Mar 2023
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle will present a company overview at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum on March 22 at 2:15 p.m. Easte
Castle Biosciences, Inc. (CSTL) Q4 2022 Earnings Call Transcript
05:50pm, Friday, 03'rd Mar 2023
Castle Biosciences, Inc. (NASDAQ:CSTL ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET Company Participants Camilla Zuckero - Vice President, Investor Relations and Corporate Affairs De
Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Tops Revenue Estimates
09:05pm, Tuesday, 28'th Feb 2023
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of 14.29% and 4.96%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the st
Castle Biosciences to Release Fourth Quarter and Full-Year 2022 Financial Results and Host Conference Call on Tuesday, Feb. 28, 2023
05:00pm, Tuesday, 07'th Feb 2023
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle will release its financial results for the fourth quarter and year ended Dec. 31, 2022, after the close of market on Tuesday, Feb. 28, 2023.
Castle Biosciences: Potential To Re-Rate With Supportive Fundamentals, Technicals, Underlying Market
04:33pm, Thursday, 15'th Dec 2022
Castle Biosciences has niche exposure to skin cancer, offering uncorrelated alpha potential. The stock is beaten down, with a chance to re-rate to the upside.
Castle Biosciences, Inc. (CSTL) Q3 2022 Earnings Call Transcript
05:46am, Thursday, 03'rd Nov 2022
Castle Biosciences, Inc. (NASDAQ:CSTL ) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Camilla Zuckero - Vice President, Investor Relations and Corporate Affairs Der
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle announced new data showing that DecisionDx-SCC test results positively impacted patient management in over 80% of a Medicare-eligible cohort
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle will present data highlighting its portfolio of skin cancer GEP tests at the 2022 ASDS Annual Meeting.
Castle Biosciences to Participate in Upcoming Investor Conferences
07:00am, Thursday, 01'st Sep 2022
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle Biosciences is scheduled to present a company overview at Baird's 2022 Global Healthcare Conference on Tuesday, Sept. 13, 2022, at 2 p.m. ET
Castle Biosciences, Inc. (CSTL) CEO Derek Maetzold on Q2 2022 Results - Earnings Call Transcript
12:57pm, Friday, 12'th Aug 2022
Castle Biosciences, Inc. (NASDAQ:CSTL ) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Camilla Zuckero - Executive Director of IR & Corporate Communications Derek Maet
Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
07:34pm, Monday, 08'th Aug 2022
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of 89.66% and 22.67%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock
Castle Biosciences to Present at the Canaccord Genuity 42nd Annual Growth Conference
07:00am, Wednesday, 03'rd Aug 2022
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle will present a company overview at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, Aug. 10, 2022, at 1:00 p.m. Eastern tim
Earnings Preview: Castle Biosciences, Inc. (CSTL) Q2 Earnings Expected to Decline
11:37am, Monday, 01'st Aug 2022
Castle Biosciences, Inc. (CSTL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
